3 Strategies for Applying Humanized Models

Immunotherapeutics have proven to be a game changer in oncology – bringing tremendous patient benefits alongside commercial success for drug developers. However, many questions still need to be answered before immuno-oncology agent use can truly be optimized, with most pressing concerns including how to predict exactly which patients and which indications will respond to any given treatment.